Roblox (RBLX) Outpaces Stock Market Gains: What You Should Know
Roblox (RBLX) closed at $74.80 in the latest trading session, marking a +1.49% move from the prior day.
In the latest trading session, Roblox (RBLX) closed at $74.80, marking a +1.49% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.83%.
Coming into today, shares of the online gaming platform had lost 11.75% in the past month. In that same time, the Consumer Discretionary sector lost 4.98%, while the S&P 500 lost 3.68%.
Wall Street will be looking for positivity from RBLX as it approaches its next earnings report date.
Investors might also notice recent changes to analyst estimates for RBLX. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.74% lower. RBLX is currently a Zacks Rank #3 (Hold).
The Gaming industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 180, putting it in the bottom 30% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Roblox Corporation (RBLX): Free Stock Analysis Report
To read this article on Zacks.com click here.